BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12865629)

  • 1. Giant cell tumor of bone. The role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis.
    Robinson D; Segal M; Nevo Z
    Pathobiology; 2002-2003; 70(6):333-42. PubMed ID: 12865629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblast lineage properties in giant cell tumors of bone.
    Murata A; Fujita T; Kawahara N; Tsuchiya H; Tomita K
    J Orthop Sci; 2005 Nov; 10(6):581-8. PubMed ID: 16307183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
    Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone.
    Roux S; Amazit L; Meduri G; Guiochon-Mantel A; Milgrom E; Mariette X
    Am J Clin Pathol; 2002 Feb; 117(2):210-6. PubMed ID: 11863217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
    Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
    J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
    Atkins GJ; Haynes DR; Graves SE; Evdokiou A; Hay S; Bouralexis S; Findlay DM
    J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
    Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
    J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
    Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T
    Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.
    Rifas L; Arackal S; Weitzmann MN
    J Cell Biochem; 2003 Mar; 88(4):650-9. PubMed ID: 12577299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
    Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytological properties of stromal cells derived from giant cell tumor of bone (GCTSC) which can induce osteoclast formation of human blood monocytes without cell to cell contact.
    Nishimura M; Yuasa K; Mori K; Miyamoto N; Ito M; Tsurudome M; Nishio M; Kawano M; Komada H; Uchida A; Ito Y
    J Orthop Res; 2005 Sep; 23(5):979-87. PubMed ID: 16024207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8.
    Valta MP; Hentunen T; Qu Q; Valve EM; Harjula A; Seppänen JA; Väänänen HK; Härkönen PL
    Endocrinology; 2006 May; 147(5):2171-82. PubMed ID: 16439448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
    Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
    J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of α-zearalanol on the proliferation of bone-marrow-derived mesenchymal stem cells and their differentiation into osteoblasts.
    Zong S; Zeng G; Fang Y; Peng J; Zou B; Gao T; Zhao J
    J Bone Miner Metab; 2016 Mar; 34(2):151-60. PubMed ID: 25944420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of the stromal cell in giant cell tumor of bone.
    Ghert M; Simunovic N; Cowan RW; Colterjohn N; Singh G
    Clin Orthop Relat Res; 2007 Jun; 459():8-13. PubMed ID: 17327805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
    J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.